Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)
4.36 x 2 4.81 x 1
Post-market by (Cboe BZX)
4.45 +0.12 (+2.77%) 04/23/25 [NASDAQ]
4.36 x 2 4.81 x 1
Post-market 4.45 unch (unch) 16:02 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.38
Day High
4.68
Open 4.50
Previous Close 4.33 4.33
Volume 1,380,600 1,380,600
Avg Vol 1,398,820 1,398,820
Stochastic %K 80.49% 80.49%
Weighted Alpha +2.35 +2.35
5-Day Change +0.13 (+3.01%) +0.13 (+3.01%)
52-Week Range 2.16 - 6.71 2.16 - 6.71
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 549,165
  • Shares Outstanding, K 126,828
  • Annual Sales, $ 482,040 K
  • Annual Income, $ 860 K
  • EBIT $ -1 M
  • EBITDA $ 24 M
  • 60-Month Beta 1.79
  • Price/Sales 1.11
  • Price/Cash Flow 20.18
  • Price/Book 2.01

Options Overview Details

View History
  • Implied Volatility 158.97% ( +2.11%)
  • Historical Volatility 79.16%
  • IV Percentile 51%
  • IV Rank 32.92%
  • IV High 408.30% on 12/23/24
  • IV Low 36.62% on 05/16/24
  • Put/Call Vol Ratio 0.25
  • Today's Volume 25
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 926
  • Open Int (30-Day) 1,771

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.04
  • Number of Estimates 1
  • High Estimate 0.04
  • Low Estimate 0.04
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.52 +26.42%
on 04/07/25
Period Open: 4.88
5.57 -20.11%
on 03/25/25
-0.43 (-8.81%)
since 03/21/25
3-Month
3.07 +44.95%
on 02/27/25
Period Open: 3.53
6.71 -33.68%
on 03/03/25
+0.92 (+26.06%)
since 01/23/25
52-Week
2.16 +105.54%
on 04/25/24
Period Open: 2.98
6.71 -33.68%
on 03/03/25
+1.47 (+49.33%)
since 04/23/24

Most Recent Stories

More News
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

ORGO : 4.45 (+2.77%)
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

ORGO : 4.45 (+2.77%)
Corcept Shares Rise More Than 55% in 6 Months: Here's Why

Shares of Corcept Therapeutics Incorporated CORT have rallied 56.4% in the past six months against the industry’s decline of 10.5%.The company’s sole-marketed drug, Korlym (mifepristone), which is...

CORT : 69.27 (+7.10%)
JAZZ : 104.19 (+0.78%)
ANIP : 68.37 (-0.84%)
ORGO : 4.45 (+2.77%)
Unbelievable Stock Gains! Why these 7 Micro, Small, and Mid-Cap Stocks Skyrocketed This Week!

Source: Shutterstock The U.S. stock market has taken a significant hit, marking one of the biggest declines in recent times. All major indices are down, largely due to economic uncertainties, including...

PRCH : 5.11 (+4.82%)
BTAI : 1.6900 (+0.60%)
MPW : 5.33 (+2.50%)
TRNR : 0.7753 (-4.43%)
OMI : 6.65 (+2.78%)
HURN : 137.21 (+1.35%)
ORGO : 4.45 (+2.77%)
ZI : 8.23 (+3.65%)
Organogenesis (ORGO) Q4 2024 Earnings Call Transcript

ORGO earnings call for the period ending December 31, 2024.

ORGO : 4.45 (+2.77%)
Organogenesis: Q4 Earnings Snapshot

Organogenesis: Q4 Earnings Snapshot

ORGO : 4.45 (+2.77%)
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

ORGO : 4.45 (+2.77%)
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

ORGO : 4.45 (+2.77%)
Insider Sale: President and CEO of $ORGO (ORGO) Sells 55,615 Shares

Gary S. Gillheeney, the President and CEO of $ORGO ($ORGO), sold 55,615 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.8%...

ORGO : 4.45 (+2.77%)
Insider Sale: President and CEO of $ORGO (ORGO) Sells 43,359 Shares

Gary S. Gillheeney, the President and CEO of $ORGO ($ORGO), sold 43,359 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4%...

ORGO : 4.45 (+2.77%)

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 4.93
2nd Resistance Point 4.81
1st Resistance Point 4.63
Last Price 4.45
1st Support Level 4.32
2nd Support Level 4.20
3rd Support Level 4.02

See More

52-Week High 6.71
Fibonacci 61.8% 4.97
Last Price 4.45
Fibonacci 50% 4.44
Fibonacci 38.2% 3.90
52-Week Low 2.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective